Nasus Pharma Ltd. (NSRX) is a Healthcare · Drug Manufacturers - General company listed on NYSE MKT. Price $3.53 (+0.00%), Market cap $0.03B.
Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel.
Financial statements, price targets, institutional (13F) holdings and related news for Nasus Pharma Ltd. are updated in real time on BlackAll Trade.
Nasus Pharma Ltd. trades at $3.53 (+0.00%). Real-time quotes and charts are available on BlackAll Trade.
Nasus Pharma Ltd. has a market cap of about $0.03B.
Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) produ